Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT07413666
PHASE1
A Study of ORX489 in Healthy Adult Participants, Aged 18 to 60 Years
Sponsor: Centessa Pharmaceuticals (UK) Limited
View on ClinicalTrials.gov
Summary
Characterize the safety, tolerability and pharmacokinetics of ORX489 following single and multiple doses.
Official title: A Safety, Tolerability, Pharmacokinetic, Food Effect, and Proof-of-Concept Study of Single and Multiple Doses of ORX489 in Healthy Adults
Key Details
Gender
All
Age Range
18 Years - 60 Years
Study Type
INTERVENTIONAL
Enrollment
212
Start Date
2026-02-25
Completion Date
2027-06-30
Last Updated
2026-02-25
Healthy Volunteers
Yes
Conditions
Interventions
DRUG
ORX489 Tablets
ORX489 Tablets
OTHER
Placebo Tablets
Placebo Tablets
Locations (1)
Celerion
Lincoln, Nebraska, United States